skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 67  for All Library Resources

Results 1 2 3 4 next page
Show only
Refined by: language: Japanese remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
Material Type:
Article
Add to My Research

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study

Blood, 2020-12, Vol.136 (26), p.3056-3061 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020007594 ;PMID: 32814348

Full text available

2
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Material Type:
Article
Add to My Research

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Blood, 2013-01, Vol.121 (3), p.537-545 [Peer Reviewed Journal]

2013 American Society of Hematology ;ISSN: 0006-4971 ;ISSN: 1528-0020 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-04-425512 ;PMID: 23169778

Full text available

3
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria
Material Type:
Article
Add to My Research

Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria

Blood, 2020-07, Vol.136 (1), p.36-49 [Peer Reviewed Journal]

2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019000940 ;PMID: 32430502

Full text available

4
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
Material Type:
Article
Add to My Research

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

The New England journal of medicine, 2008-04, Vol.358 (15), p.1547-1559 [Peer Reviewed Journal]

Copyright © 2008 Massachusetts Medical Society. All rights reserved. ;2008 INIST-CNRS ;Copyright 2008 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0801317 ;PMID: 18378520 ;CODEN: NEJMAG

Full text available

5
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
Material Type:
Article
Add to My Research

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

The New England journal of medicine, 2007-11, Vol.357 (22), p.2237-2247 [Peer Reviewed Journal]

Copyright © 2007 Massachusetts Medical Society. All rights reserved. ;2007 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa073275 ;PMID: 18046028 ;CODEN: NEJMAG

Full text available

6
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study
Material Type:
Article
Add to My Research

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study

Blood, 2019-11, Vol.134 (20), p.1708-1711 [Peer Reviewed Journal]

2019 American Society of Hematology ;2019 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019001617 ;PMID: 31570488

Full text available

7
Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure
Material Type:
Article
Add to My Research

Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure

European heart journal, 2013-01, Vol.34 (1), p.57-67 [Peer Reviewed Journal]

ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehs196 ;PMID: 22778174

Full text available

8
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study
Material Type:
Article
Add to My Research

Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study

Pediatric blood & cancer, 2016-08, Vol.63 (8), p.1407-1413 [Peer Reviewed Journal]

2016 Wiley Periodicals, Inc. ;ISSN: 1545-5009 ;EISSN: 1545-5017 ;DOI: 10.1002/pbc.26003 ;PMID: 27135461

Full text available

9
Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Material Type:
Article
Add to My Research

Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Clinical pharmacology and therapeutics, 2015-01, Vol.97 (1), p.88-102 [Peer Reviewed Journal]

2014 American Society for Clinical Pharmacology and Therapeutics ;2014 American Society for Clinical Pharmacology and Therapeutics. ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1002/cpt.10 ;PMID: 25670386

Full text available

10
Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy
Material Type:
Article
Add to My Research

Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy

The New England journal of medicine, 2004-11, Vol.351 (19), p.1952-1961 [Peer Reviewed Journal]

Copyright © 2004 Massachusetts Medical Society. All rights reserved. ;2004 INIST-CNRS ;Copyright 2004 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa042274 ;PMID: 15516696 ;CODEN: NEJMAG

Full text available

11
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice
Material Type:
Article
Add to My Research

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

International journal of hematology, 2017-10, Vol.106 (4), p.508-516 [Peer Reviewed Journal]

The Japanese Society of Hematology 2017 ;International Journal of Hematology is a copyright of Springer, 2017. ;ISSN: 0925-5710 ;EISSN: 1865-3774 ;DOI: 10.1007/s12185-017-2275-4 ;PMID: 28667351

Full text available

12
The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores
Material Type:
Article
Add to My Research

The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores

Blood, 2010-07, Vol.116 (4), p.537-543 [Peer Reviewed Journal]

2010 American Society of Hematology ;2015 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2009-11-250308 ;PMID: 20421452

Full text available

13
Deferasirox nephrotoxicity-the knowns and unknowns
Material Type:
Article
Add to My Research

Deferasirox nephrotoxicity-the knowns and unknowns

Nature reviews. Nephrology, 2014-10, Vol.10 (10), p.574-586 [Peer Reviewed Journal]

COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2014 ;ISSN: 1759-5061 ;EISSN: 1759-507X ;DOI: 10.1038/nrneph.2014.121 ;PMID: 25048549

Full text available

14
A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia
Material Type:
Article
Add to My Research

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

Haematologica (Roma), 2013-06, Vol.98 (6), p.881-887 [Peer Reviewed Journal]

Copyright© Ferrata Storti Foundation 2013 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2012.074633 ;PMID: 23445876

Full text available

15
Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia: Meta-Analysis of Randomized Controlled Trials
Material Type:
Article
Add to My Research

Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia: Meta-Analysis of Randomized Controlled Trials

Clinical and Applied Thrombosis/Hemostasis, 2017-11, Vol.23 (8), p.928-937 [Peer Reviewed Journal]

The Author(s) 2016 ;The Author(s) 2016. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content ;ISSN: 1076-0296 ;EISSN: 1938-2723 ;DOI: 10.1177/1076029616663849 ;PMID: 27572890

Full text available

16
Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study
Material Type:
Article
Add to My Research

Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study

Journal of clinical oncology, 2011-08, Vol.29 (22), p.3001-3007 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.35.1908 ;PMID: 21690476

Full text available

17
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
Material Type:
Article
Add to My Research

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

Haematologica (Roma), 2014-10, Vol.99 (10), p.1632-1637 [Peer Reviewed Journal]

Copyright© Ferrata Storti Foundation. ;Copyright© Ferrata Storti Foundation 2014 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2014.105908 ;PMID: 24997153

Full text available

18
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
Material Type:
Article
Add to My Research

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

European journal of haematology, 2016-09, Vol.97 (3), p.297-302 [Peer Reviewed Journal]

2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ;2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. ;ISSN: 0902-4441 ;EISSN: 1600-0609 ;DOI: 10.1111/ejh.12725 ;PMID: 26709028

Full text available

19
Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials
Material Type:
Article
Add to My Research

Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials

PloS one, 2013-12, Vol.8 (12), p.e82662 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Xia et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Xia et al 2013 Xia et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0082662 ;PMID: 24376563

Full text available

20
Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140)
Material Type:
Article
Add to My Research

Hepatotoxicity Observed in Clinical Trials of Aplaviroc (GW873140)

Antimicrobial Agents and Chemotherapy, 2008-03, Vol.52 (3), p.858-865 [Peer Reviewed Journal]

2008 INIST-CNRS ;Copyright © 2008 American Society for Microbiology ;Copyright © 2008, American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/aac.00821-07 ;PMID: 18070967 ;CODEN: AACHAX

Full text available

Results 1 - 20 of 67  for All Library Resources

Results 1 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (64)

Refine My Results

Creation Date 

From To
  1. Before 1986  (7)
  2. 1986 To 1993  (6)
  3. 1994 To 2003  (9)
  4. 2004 To 2011  (18)
  5. After 2011  (29)
  6. More options open sub menu

Searching Remote Databases, Please Wait